NURX
AcquiredYC W16YC Top CompanyNew York City, US · Founded 2015 · 300 employees · 9 known investors
Nurx provides accessible and affordable medications and tests through a digital health platform designed for everyone.
Also known as Nurx
Founders & leadership· Y Combinator alumni (W16)
NURX was founded in 2015 by Edvard Engesaeth.
Investors · 9
The YC application· Winter 2016 batch
Company profile
researched Aug 2026Nurx is a direct-to-consumer telemedicine service that provides online medical consultations, prescriptions, and home delivery of medication, with an initial focus on birth control and PrEP and a current focus on specialty care for women. Patients complete an online medical consultation covering health history and goals; a provider licensed in the patient's state reviews it and prescribes treatment when clinically appropriate; the prescription is then shipped to the patient's home with free shipping, automatic refills, and the ability to pause or cancel. The company also offers home testing kits and unlimited messaging with its medical team, which includes doctors, nurse practitioners, physician assistants, nurses, and pharmacists. Services are not offered in every state.
The platform advertises access to more than 150 prescription treatment options across several categories: reproductive care (50+ birth control formulas including the pill, patch, ring, and shot, plus emergency contraception), menopause care including prescription hormone replacement therapy, weight management via injectable GLP-1 and oral treatments with progress check-ins, dermatology (acne, anti-aging, melasma, rosacea, eyelash growth), mental health medication for conditions such as anxiety, depression, insomnia, PMDD, OCD, PTSD, seasonal affective disorder and postpartum depression (Nurx does not provide talk therapy or crisis management), herpes/cold sore treatment and prevention, hair loss and dandruff, and general health conditions such as UTI, bacterial vaginosis, vaginitis, yeast infection, and migraine. Medications are offered with or without insurance, with some treatments as low as $0 with insurance coverage and listed cash prices otherwise; many services are FSA/HSA eligible. A consumer mobile app is distributed via the Apple App Store.
Founding story
Nurx was founded in 2015 by Edvard Engesaeth and went through Y Combinator's Winter 2016 batch, launching as a telemedicine service aimed at increasing access to healthcare, beginning with birth control and PrEP prescribed online and delivered to patients' doors.
Business model
Nurx operates a consumer telehealth and pharmacy-fulfilment model: patients pay for asynchronous online medical consultations and for prescribed medication that is shipped to them, with recurring refill shipments (for example a three-month birth control supply) and subscription-style pause/cancel controls. Some medications are billed through insurance, where patient cost can be $0 or a copay, while uninsured patients pay listed cash prices; certain services are FSA/HSA eligible.
Revenue comes from patient payments for medications and telehealth care, both cash-pay at published prices and via accepted insurance plans, with recurring refill orders and free shipping included.
Traction
Company site reports 2M+ patients served, 16M+ birth control prescriptions issued, over 92% of patients ordering again, and 26,691+ reviews averaging 4.8 (4.7 "Excellent") on Trustpilot. Team size is listed at 300. Parent company Thirty Madison was reported to contribute more than $220M in annual revenue in connection with the 2025 Remedy Meds transaction.
Latest developments
In September 2025 it was reported that Nurx's parent Thirty Madison agreed to be acquired by Remedy Meds in an all-stock deal worth just over $500M, expected to close in late 2025; Remedy Meds reported more than $450M in annual revenue with "substantial profitability" and Thirty Madison more than $220M. Nurx's current site markets weight management (GLP-1 injection and oral), menopause care with prescription HRT, dermatology and mental health services alongside its birth control offering.
▸Full profile — market position, technology, go-to-market, geography, history, risks & controversies
Market position
Nurx presents itself as a leading online provider of birth control, citing 16M+ prescriptions issued, over 92% of patients ordering again, and "Voted #1 best provider of birth control online." Third-party coverage describes it as one of the most prominent and largest telehealth providers for birth control, sexual health and reproductive care.
Positions online care against in-person alternatives on time and cost: prescription requests any time of day, no travel or waiting-room time (versus a stated average 24-day wait for a doctor appointment and about two hours of travel and waiting), no pharmacy line, transparent pricing published on the site, unlimited provider messaging, and free discreet shipping with automatic refills.
Technology
A web and mobile platform for asynchronous online medical consultations, state-licensed provider review and e-prescribing, unlimited patient–provider messaging, home delivery of prescriptions with automatic refills, and at-home testing kits.
Go-to-market
Direct-to-consumer online acquisition through its website and mobile app, with condition-specific landing pages, transparent pricing, free discreet shipping, automatic refills, and customer review social proof (a 4.8 rating across 26,691+ Trustpilot reviews).
Primarily women seeking reproductive, sexual, menopause, dermatology, mental health, weight management and general health care online; earlier positioning also covered PrEP users. The site states more than 2 million patients have been served.
Geography
United States, with care delivered by providers licensed in the patient's state; services and specific treatments are not available in every state. Headquarters listed as New York City, NY.
History
Founded in 2015, Nurx participated in Y Combinator's Winter 2016 batch as a telemedicine startup focused on increasing healthcare access, starting with birth control and PrEP. In February 2022 it merged with telehealth company Thirty Madison, becoming part of that group's brand portfolio alongside Keeps (men's hair loss) and Cove (migraine). In September 2025, Thirty Madison agreed to be acquired by Remedy Meds in an all-stock transaction valued at just over $500M, expected to close in late 2025, placing Nurx within a multi-brand consumer health platform offering nationwide clinician access, integrated pharmacy fulfilment and same-day telehealth visits.
Risks & controversies
Service availability is constrained by state-level licensing, with several offerings noted as not available in every state and prescriptions issued only when clinically appropriate. Insurance coverage is limited to some medications and plans. For weight management, the company discloses risks including muscle loss, fatigue, menstrual changes, gallstones, mood changes, nutritional deficiencies from rapid weight loss, and weight regain. Nurx does not provide talk therapy or crisis management for mental health patients.
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Competitors · 2
by search overlapCompanies competing with NURX for the same Google search keywords, organic and paid, via search-intersection analysis.
Timeline · 3
launches, deals, and filingsThirty Madison, Nurx's parent, agreed to an all-stock acquisition by Remedy Meds valued at just over $500M, expected to close in late 2025. The deal also includes Cove (migraine) and Keeps (men's hair loss) and combines them with Remedy's weight loss business, promising nationwide clinician access, integrated pharmacy fulfilment and same-day telehealth visits.
$500M source ↗
Nurx merged with Thirty Madison, becoming part of the group's brand portfolio.
Nurx took part in Y Combinator's Winter 2016 batch as a telemedicine startup focused on increasing access to healthcare, starting with birth control and PrEP.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- NURXnurx.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does NURX do?
- Nurx is a US telehealth platform that prescribes and delivers birth control and other women's health medications online.
- Who founded NURX?
- NURX was founded by Edvard Engesaeth in 2015.
- Who are NURX's investors?
- NURX's investors include Comcast Ventures, Dreamers VC, Fifty Years, Foreground Capital, Garage Capital, Kleiner Perkins, Y Combinator, Lowercase Capital and 1 more.
- Where is NURX headquartered?
- NURX is headquartered in New York City, US.




